Today's Hours: 10:00am - 6:00pm

Search

Did You Mean:

Search Results

  • Book
    Michael Weiner, Darrell J. Yamashiro, Prakash Satwani, Monica Bhatia, Cindy Neunert.
    Summary: Pediatric Hematology & Oncology Secrets, 2nd Edition, offers practical, up-to-date coverage of the full range of essential topics in this dynamic field. This highly regarded resource features the Secrets’ popular question-and-answer format that also includes lists, tables, pearls, memory aids, and an easy-to-read style – making inquiry, reference, and review quick, easy, and enjoyable.

    Contents:
    Coagulation overview
    Developmental erythropoiesis
    Sickle cell syndromes
    Intrinsic and extrinsic red blood cell defects
    Thalassemias
    Nutritional anemia
    Granulocytes
    Disorders of platelets
    Bone marrow failure syndromes
    Hematological manifestations of systemic disease
    Epidemiology
    Principles of chemotherapy
    Principles of immunotherapy
    Precision medicine and systems biology
    Predisposition syndromes
    Health equity and disparities in pediatric and adolescent/young adult oncology
    Clinical emergencies in children with cancer
    Transfusion medicine
    Pediatric radiation oncology
    Principles of infectious disease and management of febrile neutropenia
    Neoplastic hematopathology
    Pediatric solid tumors pathology
    Molecular pathology
    Survivorship and late effects
    Integrative therapies
    Palliative Care
    An overview of the Emotional and educational needs of children with hematological and oncological conditions
    Global health issues in pediatric oncology
    Principles of pediatric surgical oncology
    Acute lymphoblastic leukemia
    Acute myeloid leukemia
    Chronic myeloid leukemia/other leukemia
    Soft tissue sarcomas
    Bone tumors
    Neuroblastoma
    Hepatic tumors
    Kidney tumors in children and adolescents
    Hodgkin lymphoma in children and adolescents
    Non-hodgkin lymphoma in children and adolescents
    Neuro-Oncology
    Post-Transplant lymphoproliferative disorder (PTLD)
    Retinoblastoma
    Langerhans Cell Histiocytosis (LCH)
    Hemophagocytic lymphohistiocytosis
    Principles and practice of pediatric hematopoietic cell transplantation
    Autologous hematopoietic stem cell transplantation for children and young adults
    Car-T cells: expanding the universe of immunotherapy in children with malignant diseases
    Gene therapy for hemoglobinopathies and other diseases
    Hematopoietic cell transplantation for malignant disorders
    Stem cell transplantation for children with nonmalignant disorders
    Complications associated with allogeneic hematopoietic cell transplantation in children.
    Digital Access ClinicalKey 2024
  • Article
    Crout JR.
    Ann Intern Med. 1978 Nov;89(5 Pt 2 Suppl):832-4.
    The Food and Drug Administration recently has published general guidelines for the clinical evaluation of drugs used in adults and in infants and children. Specific guidelines for a number of drug classes, including anti-infective drugs, are also available. Marketing approval of a new drug requires that its benefits be judged to exceed its risks, that it be accurately and truthfully labeled, and that it be manufactured properly. Foreign studies are commonly accepted in support of new drugs, but approval requires at least one domestic trial unless the disease does not occur in the United States (for examply, tropical diseases).
    Digital Access Access Options